← Leaderboards
James Wise
Westat, Inc.
$2,316,674
Attributed
$2,316,674
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $821.5K · FY2022–24$1M$750K$500K$250K$0
'22
'23
'24
Funding mix
By agency
NIH$2,316,674 · 1
By mechanism
N01$2,316,674 · 1
Top collaborators
No co-investigators on record.
Most similar at Westat, Inc.
Same institution · by research overlap
- Barbara Driver$270,069,085
- Marsha Dunn$12,357,555
- Sunitha Mathew$31,488,437
- Barbara B O'Brien$43,215,006
- Russell Walker$15,990,748
Others in their field
Other Rising Stars on “Update”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Maximilian Haeussler · University Of California Santa Cruz$12,592,563
- James Cappo · National Jewish Health$9,298,220
- April Carson · University Of Mississippi Med Ctr$9,022,104
- Nancy Jean Sullivan · Boston University Medical Campus$7,541,758
- Joshua Smith · International Association Fire Fighters$7,465,346
Research focus
UpdateClinical TrialsCollectionComputer SoftwareContractorDatabasesDecision AnalysisTrainingCancer Trials Support UnitHealth DataHuman ResourcesLibrariesLife Cycle StagesMethodologyMigrationNational Cancer InstitutePatient Outcomes AssessmentsPerformanceProgramsQuestionnairesRecommendationResourcesServicesElectronic Patient Reported Outcomes
Grant awards (3)
CANCER TRIALS SUPPORT UNIT IDIQ: TASK ORDER 6A: ELECTRONIC PATIENT-REPORTED OUTCOMES (PROS)$677,170
N01 · FY2024 · CA · contact PI
CANCER TRIALS SUPPORT UNIT IDIQ: TASK ORDER 6A: ELECTRONIC PATIENT-REPORTED OUTCOMES (PROS)$818,041
N01 · FY2023 · CA · contact PI
CANCER TRIALS SUPPORT UNIT IDIQ: TASK ORDER 6A: ELECTRONIC PATIENT-REPORTED OUTCOMES (PROS)$821,463
N01 · FY2022 · CA · contact PI